4917_DEFStanislas VEILLET – PhD, – Chairman – CEO

Stanislas Veillet created Biophytis in September 2006. He previously held a number of positions in the fields of medical research, nutrition and functional foods, in particular with Danone, Pharmacia-Monsanto and Cargill. Stanislas has a doctorate in genetics, graduated in engineering from AgroParisTech and has authored a dozen patents.


Professor  Jean MARIANI – Chief Medical Officer

Director of the Institut de la Longévité Charles Foix [Longevity Institute], and a practitioner at the hospital, director of the CNRS-UPMC (UMR 7102) Laboratoire de Neurobiologie des Processus Adaptatifs [Laboratory of Neurobiology of Adaptive Processes], Professor Jean Mariani is an expert in neurobiology, central nervous system and pathologies, and neurodegenerative illnesses. He is also Emeritus Professor (PU-PH) at the Sorbonne University’s School of Medicine, and Member of the Board and Executive committee of Gerond’IF.

Evelyne NGUYEN – Chief Financial Officer

Evelyne Nguyen has over 25 years of healthcare and finance experience with biotech and pharma companies including LFB Group, where she was CFO- Senior Vice President Finance and Strategy and Bristol Myers Squibb. Prior to Joining Biophytis she was Senior Corporate Finance Advisor at ANM Partners. In this role she worked with a number of life science companies providing strategic counsel as well as financial and fund-raising support. Evelyne also has significant business development experience in Asia, including China.


Pierre J. DILDA – PhD – Chief Scientific Officer

PhD in Pharmacology (Paris V University), Dr. Dilda has more than 20 years of experience in pharmaceutical research, in both academic and industrial settings (Mayoli Spindler Laboratories). Before joining Biophytis in December 2015, he was Senior Research Fellow at the Lowy Cancer Research Center at the University of New South Wales (UNSW) in Sydney, Australia, where he was responsible for advancing several cancer therapeutics.

4630_DEFWaly DIOH – PhD – Chief Operating Officer

With a doctorate in phytopathology (Paris XI), Waly Dioh spent most of his career with R&D teams in Monsanto, initially in France to set up a genotyping platform and then in the United States (Saint Louis – Missouri) where he ran a regulatory affairs team for the development of biotechnology products. He joined Biophytis at the inception and manages current clinical trials.